Anticorps Monoclonal anti-p21
p21 Monoclonal Antibody for IF/ICC, ELISA
Hôte / Isotype
Mouse / IgG2b
Réactivité testée
souris
Applications
IF/ICC, ELISA
Conjugaison
Non conjugué
CloneNo.
3C7D3
N° de cat : 67362-1-PBS
Synonymes
Galerie de données de validation
Informations sur le produit
67362-1-PBS cible p21 dans les applications de IF/ICC, ELISA et montre une réactivité avec des échantillons souris
| Réactivité | souris | 
| Hôte / Isotype | Mouse / IgG2b | 
| Clonalité | Monoclonal | 
| Type | Anticorps | 
| Immunogène | p21 Protéine recombinante Ag28394 | 
| Nom complet | cyclin-dependent kinase inhibitor 1A (P21) | 
| Masse moléculaire calculée | 18 kDa | 
| Numéro d’acquisition GenBank | NM_001111099 | 
| Symbole du gène | p21 | 
| Identification du gène (NCBI) | 12575 | 
| Conjugaison | Non conjugué | 
| Forme | Liquide | 
| Méthode de purification | Purification par protéine A | 
| Tampon de stockage | PBS only | 
| Conditions de stockage | Store at -80°C. 20ul contiennent 0,1% de BSA. | 
Informations générales
CDKN1A (p21, CIP1, WAF1) is a cyclin-dependent kinase inhibitor. CDKN1A binds to and inhibits the activity of cyclin-CDK2 or -CDK4 complexes, and thus functions as a regulator of cell cycle progression at the G1 phase. The expression of CDKN1A is induced by wild-type but not mutant p53 protein, through which CDKN1A mediates the p53-dependent cell cycle G1 phase arrest in response to a variety of stress stimuli. CDKN1A can interact with proliferating cell nuclear antigen (PCNA), and plays a regulatory role in S phase DNA replication and DNA damage repair. CDKN1A was reported to be specifically cleaved by CASP3-like caspases, which thus leads to a dramatic activation of CDK2, and may be instrumental in the execution of apoptosis following caspase activation.

